In 1961, Robert Guthrie developed a method to test newborns for phenylketonuria, or PKU ? a genetic disorder that prevents the body from processing a protein found in almost all food, causing severe mental retardation.
UT Southwestern Medical Center researchers have discovered a treatment that counteracts the effects of cocaine on the human cardiovascular system, including lowering the elevated heart rate and blood pressure often found in cocaine users.
Racial differences in breast cancer survival increase according to stage of disease, a new study finds. Published in the September 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, a retrospective analysis of survival data demonstrates that within each stage, African American women had larger tumors and were more likely to have disease that had spread to nearby lymph nodes.
In an editorial, to be published in the international journal Osteoarthritis and Cartilage, published by Elsevier, a panel of arthritis research experts has recommended that coxibs and nonsteroidal anti-inflammatory drugs must remain a significant part of the tool kit used in treating osteoarthritis.
The Province has allocated the $100-million Health Innovation Fund to British Columbia?s six health authorities, announced Health Minister George Abbott today.
Abbott has received a supplemental Premarket Approval from the U.S. Food and Drug Administration for its recently introduced RealTime HIV-1 viral load test.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Solvay Pharmaceuticals, Inc. announced the receipt of an action letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for bifeprunox, an atypical antipsychotic that was reviewed for the acute treatment of schizophrenia, as well as the maintenance of stable adult patients.
Scientists have provided new insight into how a gene is related to schizophrenia. In a study to be published in the August 17 issue of the Journal of Biological Chemistry, Amanda J. Law, Medical Research Council Fellow and Associate Professor at the University of Oxford, United Kingdom, and Visiting Scientist at the National Institutes of Health (NIH), along with colleagues at NIH describe for the first time a genetic variation that causes a gene to be overexpressed in the human brain. These results may provide a new way to design better drugs to treat schizophrenia.
Is there a definitive test for mental illness? Not yet, but using advanced neuropsychiatric diagnostic tools including magnetic resonance imaging (MRI) and positron emission tomography (PET), mental health professionals at The Menninger Clinic in Houston are pinpointing the causes of behavioral and psychiatric problems in patients.
The Juvenile Products Manufacturers Association (JPMA), which represents the leading manufacturers of baby bottles in the United States is aware of the panel evaluation of bisphenol A, organized by the Center for the Evaluation of Risks to Human Reproduction (CERHR).